ClearPoint Neuro, Inc. (CLPT) revenue by segment
CLPTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 4/3010% above fair value
$7.71−0.15 (-1.91%)
Close on Nov 18, 2026Market cap $247.14MP/E –Yield –
Doanh thu theo bộ phận của ClearPoint Neuro, Inc.
Theo bộ phận kinh doanh
Theo sản phẩm hoặc dịch vụ
| Doanh thu | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | % doanh thu | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Product revenue | $23.86M | $18.63M | $10.60M | $12.79M | $11.91M | $8.83M | $9.80M | $6.69M | $7.02M | 64.5% | +28.1% |
| Biologics and drug delivery | $19.04M | $17.31M | $13.60M | $9.12M | $6.80M | $5.20M | $2.41M | $951.94K | $675.81K | 51.5% | +10.0% |
| Neurosurgery navigation and therapy | $14.83M | $10.29M | $8.52M | – | – | – | – | – | – | 40.1% | +44.2% |
| Neurosurgery Navigation and Therapy - Disposable Products | $14.83M | $10.29M | $7.59M | – | – | – | – | – | – | 40.1% | +44.2% |
| Service and other revenue | $13.11M | $12.76M | $13.35M | $7.76M | $4.39M | $4.00M | $1.42M | $668.25K | $355.52K | 35.5% | +2.7% |
| Biologics and Drug Delivery - Services and License Fees | $11.70M | $11.70M | $11.45M | $5.43M | $3.44M | – | – | – | – | 31.7% | -0.0% |
| Biologics and Drug Delivery - Disposable Products | $7.34M | $5.61M | $2.15M | $3.69M | $3.35M | $1.53M | $1.52M | $913.42K | – | 19.8% | +30.9% |
| Capital equipment and software | $3.10M | $3.80M | $1.83M | $2.31M | $1.43M | $1.42M | $1.66M | – | – | 8.4% | -18.3% |
| Capital Equipment and Software-Related Service | $2.10M | $2.30M | – | – | – | – | – | – | – | 5.7% | -8.7% |
| Capital Equipment and Software - Systems and Software Products | $1.69M | $2.74M | $860.00K | $1.51M | $864.00K | $1.09M | $1.36M | $420.04K | – | 4.6% | -38.2% |
| Capital Equipment and Software - Services | $1.41M | $1.06M | $973.00K | $795.00K | $569.00K | $325.00K | $306.00K | $393.02K | – | 3.8% | +33.0% |
| Capital Equipment Related Service Revenue | – | $2.30M | $1.10M | – | – | $500.00K | $228.00K | $142.61K | – | – | – |
| Neurosurgery Navigation and Therapy - Services | – | $0 | $931.00K | – | – | – | – | – | – | – | – |
| Functional neurosurgery navigation and therapy | – | – | $8.52M | $9.12M | $8.07M | $6.21M | $7.14M | – | – | – | – |
| Functional Neurosurgery Navigation and Therapy - Services | – | – | $931.00K | $1.54M | $375.00K | $0 | $225.00K | – | – | – | – |
| Functional Neurosurgery Navigation and Therapy - Disposable Products | – | – | $7.59M | $7.59M | $7.70M | $6.21M | $6.92M | – | – | – | – |
| Biologics and Drug Delivery - Services | – | – | – | – | $3.44M | $3.67M | $890.00K | $175.22K | – | – | – |
| Remaining Performance Obligations Capital Equipment-Related Service Revenue | – | – | – | – | – | $500.00K | $1.10M | $303.91K | – | – | – |
| Functional Neurosurgery Navigation - Disposable Products | – | – | – | – | – | – | $6.88M | $5.31M | – | – | – |
| Therapy - Disposable Products | – | – | – | – | – | – | $96.93K | – | – | – | – |
| Product - Product Revenue | – | – | – | – | – | – | $9.48M | $6.69M | – | – | – |
| Services - Service Revenue | – | – | – | – | – | – | $1.74M | $668.25K | – | – | – |
| Therapy - Services | – | – | – | – | – | – | $225.00K | $100.00K | – | – | – |
| Functional Neurology | – | – | – | – | – | – | – | $5.31M | $5.23M | – | – |
| Capital Equipment | – | – | – | – | – | – | – | $420.04K | $1.12M | – | – |
| Capital Equipment and Other | – | – | – | – | – | – | – | $393.02K | $355.52K | – | – |
Theo khu vực
Lấy từ thuyết minh bộ phận và phân tách doanh thu trong hồ sơ 10-K, 10-Q của ClearPoint Neuro (XBRL). Số quý 4 bằng cả năm tài chính trừ chín tháng đầu. Tên bộ phận giữ theo cách công ty tự đặt và có thể đổi khi công ty tái cấu trúc. Tab KPI hiện các bộ phận này cạnh chỉ số vận hành của ClearPoint Neuro, kèm đầy đủ lịch sử, biểu đồ và liên kết tới từng hồ sơ.
See a number that looks wrong?